Donatussin (Laser Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Donatussin drug offered from Laser Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Laser Pharmaceuticals, LLC
NON-PROPRIETARY NAME: Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride
SUBSTANCE NAME: CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SYRUP
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-09-28
END MARKETING DATE: 0000-00-00


Donatussin HUMAN OTC DRUG Details:

Item DescriptionDonatussin from Laser Pharmaceuticals, LLC
LABELER NAME: Laser Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5; 120; 5(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2011-09-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16477-185_4451a110-89c8-4c99-9caa-39cc46178488
PRODUCT NDC: 16477-185
APPLICATION NUMBER: part341

Other CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laser Pharmaceuticals, LLCDonatussin
Portal PharmaceuticalClophed